Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Ziyang Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, RNA, Small Interfering, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Perturbations in autophagy, apoptosis and differentiation have greatly affected the progression and therapy of acute myeloid leukaemia (AML). The role of X‐linked inhibitor of apoptosis (XIAP)‐related autophagy remains unclear in AML therapeutics. Here, we found that XIAP was highly expressed and associated with poor overall survival in patients with AML. Furthermore, pharmacologic inhibition of XIAP using birinapant or XIAP knockdown via siRNA impaired the proliferation and clonogenic capacity by inducing autophagy and apoptosis in AML cells. Intriguingly, birinapant‐induced cell death was aggravated in combination with ATG5 siRNA or an autophagy inhibitor spautin‐1, suggesting that autophagy may be a pro‐survival signalling. Spautin‐1 further enhanced the ROS level and myeloid differentiation in THP‐1 cells treated with birinapant. The mechanism analysis showed that XIAP interacted with MDM2 and p53, and XIAP inhibition notably downregulated p53, substantially increased the AMPKα1 phosphorylation and downregulated the mTOR phosphorylation. Combined treatment using birinapant and chloroquine significantly retarded AML progression in both a subcutaneous xenograft model injected with HEL cells and an orthotopic xenograft model injected intravenously with C1498 cells. Collectively, our data suggested that XIAP inhibition can induce autophagy, apoptosis and differentiation, and combined inhibition of XIAP and autophagy may be a promising therapeutic strategy for AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Institute of Hematology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Wenzhou Key Laboratory of Hematology, Wenzhou, Zhejiang, China.
- Central Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Laboratory Animal Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Shenghui Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, Z., Zhou, J., Jiang, Y., Han, Y., Wang, X., Li, F., Jiang, S., Yu, K., & Zhang, S. (2023). Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17765
Vancouver
Huang Z, Zhou J, Jiang Y, Han Y, Wang X, Li F, et al. Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17765
BibTeX
@article{Huang2023,
author = {Huang, Ziyang and Zhou, Jifan and Jiang, Yinyan and Han, Yixiang and Wang, Xiaofang and Li, Fanfan and Jiang, Songfu and Yu, Kang and Zhang, Shenghui},
title = {Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17765}
}
EUVIMED